세계의 맵핑 카테터 시장 : 규모, 점유율, 동향 분석(기술별, 적응증별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

Mapping Catheters Market Size, Share & Trends Analysis Report By Technology (High-Density (HD) Mapping, Contact Force Sensing), By Indication (AF, AFL, VT), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,242,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,398,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

세계의 매핑 카테터 시장 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 매핑 카테터 시장 규모는 2025년부터 2030년까지 연평균 복합 성장률(CAGR) 8.9%로 성장을 지속하고, 2030년에는 49억 6,000만 달러에 달할 전망입니다. 2023년 8월에 발표된 Heart Rhythm Society의 논문에 따르면, 심방세동(AFib)은 미국의 600만명을 포함한 전 세계에서 약 4,000만명이 이환되고 있으며, 가장 만연하고 있는 심장 부정맥입니다. 이런 툴은 부정맥 부위를 핀포인트에서 파악하고, 겨냥한 치료를 유도하고, 궁극적으로 환자의 예후를 개선하고, 뇌졸중과 심부전과 같은 심각한 합병증의 위험을 줄이기 위해 필수적이기 때문입니다.

매핑 시스템의 기술 진보가 시장 성장의 원동력이되고 있습니다. 예를 들어, 2024년 6월에는 다전극 바구니 카테터, 심장 동맥 및 심외막 정맥을 매핑할 수 있는 장치와 같은 새로운 도구가 진공 치료 중에도 심장 활성화 시퀀싱의 상세한 3차원 시각화를 가능하게 합니다. 또한, 컴퓨터화된 비접촉 매핑 시스템은 심내막 표면에 직접 접촉하지 않고 전위도를 재구성하고 3D 동전위 맵을 만드는 알고리즘을 활용하여 전기 생리학에 변화를 가져옵니다. 이러한 기술적 진보를 보완하는 것은 원격 모니터링과 감염 제어의 개선으로, 병원 환경 밖에서의 지속적인 심박 평가가 가능해져, 환자의 안전성이 향상되고, 적시에 치료 개입이 가능해져, 침습적 처치에 수반되는 리스크가 최소화됩니다.

게다가 시장 진출 기업에 의한 전략적 이니셔티브 증가는 시장 성장을 뒷받침하고 있습니다. 예를 들어, 2024년 5월, Johnson & Johnson의 의학기술 기업인 심장 부정맥 치료의 세계 리더인 Biosense Webster는 3D 심장 매핑 플랫폼의 고급 신판인 CARTO 3 시스템 버전 8을 발표했습니다. 이 업그레이드는 심방 세동과 같은 부정맥에 대한 카테터 절제 치료의 정확성과 절차 효율성을 향상시킵니다. 최신 추가 기능 중에는 CARTO ELEVATE(TM) 및 CARTOSOUND(TM) FAM 모듈이 있으며, 모두 복잡한 절제 절차에서 정확성, 일관성 및 워크플로우 개선으로 전기 생리학자를 지원하기 위해 개발되었습니다.

매핑 카테터 시장 : 분석 개요

• 고밀도(HD) 매핑 부문이 2024년에 49.3% 이상의 최대 점유율을 차지했습니다.
• 심방세동(AF) 부문은 심방세동 발생률 증가, 주요 기업에 의한 이니셔티브 확대, 기술 진보로 2024년 66.8% 초과의 최대 점유율을 차지했습니다.
• 병원 부문은 2024년 36.8%로 최대의 점유율을 차지했습니다.
• 북미는 2024년 40.4%의 점유율을 차지하여 시장을 독점했습니다.
• 이 시장에는 Abbott Laboratories, Acutus Medical, Johnson End Johnson, Medtronic, Boston Scientific Corporation, Microport Scientific Corporation, Rep Medical, Stereo Taxis 및 Koninklijke Philips NV가 포함되어 있습니다.

목차

제1장 분석 방법 및 범위

제2장 주요 요약

제3장 매핑 카테터 시장 : 변동 요인, 경향, 범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 매핑 카테터 시장 : 분석 도구
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 매핑 카테터 시장 : 기술별 추정 및 동향 분석

• 매핑 카테터 시장 : 기술별 대시보드
• 매핑 카테터 시장 : 기술별 변동 분석
• 매핑 카테터 시장 : 시장 규모 예측과 동향 분석 : 기술별(2018-2030년)
• 고밀도(HD) 매핑
• 접촉력 감지
• 기타

제5장 매핑 카테터 시장 : 적응증별 추정 및 동향 분석

• 매핑 카테터 시장 : 적응증별 대시보드
• 매핑 카테터 시장 : 적응증별 변동 분석
• 매핑 카테터 시장 : 시장 규모 예측과 동향 분석 : 적응증별(2018-2030년)
• 심방세동(AF)
• 심방 조동(AFL)
• 심실 빈맥(VT)
• 기타

제6장 매핑 카테터 시장 : 최종 용도별 추정 및 동향 분석

• 매핑 카테터 시장 : 최종 용도별 대시보드
• 매핑 카테터 시장 : 최종 용도별 변동 분석
• 매핑 카테터 시장 : 시장 규모 예측과 동향 분석 : 최종 용도별(2018-2030년)
• 병원
• 외래수술센터(ASC)
• 기타

제7장 매핑 카테터 시장 : 지역별 추정 및 동향 분석(국가별, 기술별, 적응증별, 최종 용도별)

• 세계의 매핑 카테터 시장 : 지역별 대시보드
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 스웨덴
  • 노르웨이
  • 덴마크
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 남아프리카
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 최근의 동향과 영향 분석 : 주요 제조업체별
• 기업/경쟁의 분류
• 벤더 상황
  • 주요 유통업체·채널 파트너 목록
  • 주요 고객
  • 주요 기업의 시장 점유율 분석(2024년)
  • Abbott Laboratories
  • Acutus Medical, Inc.
  • Johnson & Johnson
  • Medtronic
  • Boston Scientific Corporation
  • Microport Scientific Corporation
  • Lepu Medical
  • Stereotaxis, Inc.
  • Koninklijke Philips NV

JHS

영문 목차

영문목차

Mapping Catheters Market Growth & Trends:

The global mapping catheters market size is expected to reach USD 4.96 billion by 2030, registering a CAGR of 8.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are the rising cases of CVD, increasing arrhythmia (AF) incidence, technological advancements, and government initiatives. According to the (HRS) Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib) affects nearly 40 million individuals globally, including 6 million in the United States, making it the most prevalent cardiac arrhythmia. Almost one in four adults over 40 face the risk of developing AFib, often without recognizing early symptoms; the demand for timely and accurate diagnosis is skyrocketing. This rising need fuels the market, as these tools are essential for pinpointing arrhythmic sites and guiding targeted treatment, ultimately improving patient outcomes and reducing the risk of serious complications like stroke and heart failure.

Technological advancements in mapping systems are driving market growth. For instance, in June 2024, New tools like multielectrode basket catheters and devices capable of mapping cardiac arteries and epicardial veins enable detailed three-dimensional visualization of cardiac activation sequences, even during vacuum therapy. Additionally, computerized non-contact mapping systems transform electrophysiology by leveraging algorithms to reconstruct electrograms and create 3D isopotential maps without direct contact with the endocardial surface. These technological strides are complemented by remote monitoring and infection control improvements, which allow continuous heart rhythm assessment outside of hospital environments-enhancing patient safety, enabling timely therapeutic interventions, and minimizing risks associated with invasive procedures.

Moreover, the rising strategic initiatives by the market players fuel market growth. For instance, in May 2024, Biosense Webster, a Johnson & Johnson MedTech company and a global leader in treating cardiac arrhythmias, introduced CARTO 3 System Version 8, an advanced iteration of its 3D cardiac mapping platform. This upgrade enhances precision and procedural efficiency during catheter ablation treatments for arrhythmias like atrial fibrillation. Among the latest additions are the CARTO ELEVATE(TM) and CARTOSOUND(TM) FAM Modules, both developed to support electrophysiologists with improved accuracy, consistency, and workflow during complex ablation procedures.

Mapping Catheters Market Report Highlights:

• The High-Density (HD) mapping segment held the largest share of over 49.3% in 2024. The increasing incidence of AF and technological advancement drives the segment growth. High-Density (HD) Mapping is a technique that captures detailed electrical signals from the heart for precise arrhythmia diagnosis and treatment
• The Atrial Fibrillation (AF) segment held the largest share, over 66.8%, in 2024 due to the increasing incidence of AF, growing initiatives by key players, and technological advancements
• The hospital segment held the largest share at 36.8% in 2024. Hospitals increasingly perform catheter procedures, reflecting the growing demand for advanced electrophysiological interventions
• North America dominated the market, with a share of 40.4% in 2024, owing to the increasing prevalence of cardiac arrhythmia, including increasing cardiac procedures and technological advancements
• Market players operating in the market include Abbott Laboratories, Acutus Medical, Inc., Johnson & Johnson, Medtronic, Boston Scientific Corporation, Microport Scientific Corporation, Lepu Medical, Stereotaxis, Inc., and Koninklijke Philips N.V.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Indication
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology Segment
  • 2.2.2. Indication Segment
  • 2.2.3. End-use Segment
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Mapping Catheters Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cardiac arrhythmias
    • 3.2.1.2. Increased cardiac procedures
    • 3.2.1.3. Technological advancements
    • 3.2.1.4. Growing awareness of early detection of AF
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost associated with the devices and procedures
    • 3.2.2.2. Regulatory compliance
• 3.3. Mapping Catheters Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Mapping Catheters Market: Technology Estimates & Trend Analysis

• 4.1. Mapping Catheters Market: Technology Dashboard
• 4.2. Mapping Catheters Market: Technology Movement Analysis
• 4.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by Technology, 2018 - 2030 (USD Million)
• 4.4. High-Density (HD) Mapping
  • 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 4.5. Contact Force Sensing
  • 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Mapping Catheters Market: Indication Estimates & Trend Analysis

• 5.1. Mapping Catheters Market: Indication Dashboard
• 5.2. Mapping Catheters Market: Indication Movement Analysis
• 5.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by Indication, 2018 - 2030 (USD Million)
• 5.4. Atrial Fibrillation (AF)
  • 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 5.5. Atrial Flutter (AFL)
  • 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 5.6. Ventricular Tachycardia (VT)
  • 5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Mapping Catheters Market: End-use Estimates & Trend Analysis

• 6.1. Mapping Catheters Market: End-use Dashboard
• 6.2. Mapping Catheters Market: End-use Movement Analysis
• 6.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by End-use, 2018 - 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Mapping Catheters Market: Regional Estimates & Trend Analysis by Country, Technology, Indication, & End-use

• 7.1. Global Mapping Catheters Market: Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 - 2030
• 7.3. North America
  • 7.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework/ reimbursement structure
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.9. Denmark
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework/ reimbursement structure
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. South Africa
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Abbott Laboratories
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Acutus Medical, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Johnson & Johnson
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Medtronic
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Boston Scientific Corporation
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Microport Scientific Corporation
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Lepu Medical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Stereotaxis, Inc.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Koninklijke Philips N.V.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives

관련자료